Homologous and heterologous prime boost vaccinations with distinct variants of Plasmodium vivax circumsporozoite protein (CSP) protects mice against transgenic PB/PV sporozoite challenge
Vaccine development against Plasmodium vivax malaria lags behind that for Plasmodium falciparum. To narrow this gap, we administered recombinant antigens based on P. vivax circumsporozoite protein (CSP) to mice.
主要な著者: | , , , , , , , , , , , , |
---|---|
フォーマット: | Conference item |
出版事項: |
American Society of Tropical Medicine and Hygiene
2017
|